Becker's Healthcare June 25, 2024
Some Blue Cross Blue Shield companies say weight loss drugs have played a part in recent financial challenges, and one plan has made the decision to roll back benefits.
Five updates about weight loss drugs and BCBS:
BCBS Michigan said it will no longer cover GLP-1 drugs to treat obesity beginning in January. The change will affect nearly 10,000 members in fully insured, large group commercial plans.
The company cited concerns over safety, effectiveness and cost as the reasons for the decision.
BCBS Association published research in May that found 58% of patients taking weight loss drugs discontinue use of their medication before reaching a clinically meaningful health benefit.
Highmark Health, which operates BCBS affiliates in...